Literature DB >> 10705255

Pathogenesis of lung disease in cystic fibrosis.

R Dinwiddie1.   

Abstract

Lung disease in cystic fibrosis is primarily due to a defect in the cystic fibrosis transmembrane regulating protein (CFTR). This results in abnormal chloride transfer across epithelial membranes causing an excessively viscid mucus lining of the airways. Bacterial invasion particularly with Staphylococcus aureus, Haemophilus influenzae and Pseudomonas aeruginosa stimulates a vigorous and excessive primarily neutrophil-driven inflammatory response throughout the lungs. Products of this inflammation not only damage incoming bacteria but also the host tissue itself. Over a period of years this chronic suppurative process results in permanent ongoing lung destruction principally manifested as bilateral bronchiectasis. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10705255     DOI: 10.1159/000029453

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  12 in total

1.  Magnetomotive optical coherence elastography for relating lung structure and function in Cystic Fibrosis.

Authors:  Raghav K Chhetri; Jerome Carpenter; Richard Superfine; Scott H Randell; Amy L Oldenburg
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2010

2.  N-glycosylation augmentation of the cystic fibrosis epithelium improves Pseudomonas aeruginosa clearance.

Authors:  Ashley T Martino; Christian Mueller; Sofia Braag; Pedro E Cruz; Martha Campbell-Thompson; Shouguang Jin; Terence R Flotte
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-06       Impact factor: 6.914

3.  Roles of Vibrio fischeri and nonsymbiotic bacteria in the dynamics of mucus secretion during symbiont colonization of the Euprymna scolopes light organ.

Authors:  Spencer V Nyholm; Bart Deplancke; H Rex Gaskins; Michael A Apicella; Margaret J McFall-Ngai
Journal:  Appl Environ Microbiol       Date:  2002-10       Impact factor: 4.792

4.  Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamides.

Authors:  Yi Li; Qingliang Yang; Dengfeng Dou; Kevin R Alliston; William C Groutas
Journal:  Bioorg Med Chem       Date:  2007-10-18       Impact factor: 3.641

Review 5.  T cell-mediated host immune defenses in the lung.

Authors:  Kong Chen; Jay K Kolls
Journal:  Annu Rev Immunol       Date:  2013       Impact factor: 28.527

Review 6.  Inhaled mannitol for cystic fibrosis.

Authors:  Sarah J Nevitt; Judith Thornton; Clare S Murray; Tiffany Dwyer
Journal:  Cochrane Database Syst Rev       Date:  2018-02-09

7.  Unique microbial communities persist in individual cystic fibrosis patients throughout a clinical exacerbation.

Authors:  Katherine E Price; Thomas H Hampton; Alex H Gifford; Emily L Dolben; Deborah A Hogan; Hilary G Morrison; Mitchell L Sogin; George A O'Toole
Journal:  Microbiome       Date:  2013-11-01       Impact factor: 14.650

8.  Inhaled mannitol for cystic fibrosis.

Authors:  Sarah J Nevitt; Judith Thornton; Clare S Murray; Tiffany Dwyer
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

Review 9.  Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.

Authors:  Laura A Porter; Joanna B Goldberg
Journal:  Front Cell Infect Microbiol       Date:  2011-11-18       Impact factor: 5.293

Review 10.  Gender differences in bronchiectasis: a real issue?

Authors:  Celine Vidaillac; Valerie F L Yong; Tavleen K Jaggi; Min-Min Soh; Sanjay H Chotirmall
Journal:  Breathe (Sheff)       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.